N@N

CHELMSFORD, Mass.--([ BUSINESS WIRE ])--ZOLL Medical Corporation (NASDAQ:ZOLL), a manufacturer of medical devices and related software solutions, today announced it will report its first quarter results following the close of the market on January 19, 2012. The Company will hold a conference call on that date at 5:00 p.m. Eastern Time (EST) to discuss its quarterly results, business highlights and outlook.

This call will be webcast by Thomson Reuters and can be accessed at ZOLL's web site at [ www.zoll.com ].

The webcast will also be distributed through the Thomson Reuters StreetEvents Network. Individual investors can listen to the call at [ www.earnings.com ], Thomson Reutersa individual investor portal, powered by StreetEvents. Institutional investors can access the call via StreetEvents [ www.streetevents.com ], a password-protected event management site.

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008 and 2009, ZOLL was also designated in 2011 as one of Forbes Top 100 Small Public Companies in America with annual revenues under $1 billion. ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit [ www.zoll.com ].